Medicenna Therapeutics Corp Stock Technical Analysis

MDNA Stock  CAD 1.79  0.09  4.79%   
As of the 12th of December 2024, Medicenna Therapeutics secures the Standard Deviation of 5.65, mean deviation of 4.16, and Risk Adjusted Performance of (0.01). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medicenna Therapeutics, as well as the relationship between them.

Medicenna Therapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Medicenna, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Medicenna
  
Medicenna Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Medicenna Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Medicenna Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Medicenna Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Medicenna Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Medicenna Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Medicenna Therapeutics Trend Analysis

Use this graph to draw trend lines for Medicenna Therapeutics Corp. You can use it to identify possible trend reversals for Medicenna Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Medicenna Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Medicenna Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Medicenna Therapeutics Corp applied against its price change over selected period. The best fit line has a slop of   0.0068  , which may suggest that Medicenna Therapeutics Corp market price will keep on failing further. It has 122 observation points and a regression sum of squares at 1.77, which is the sum of squared deviations for the predicted Medicenna Therapeutics price change compared to its average price change.

About Medicenna Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Medicenna Therapeutics Corp on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Medicenna Therapeutics Corp based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Medicenna Therapeutics price pattern first instead of the macroeconomic environment surrounding Medicenna Therapeutics. By analyzing Medicenna Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Medicenna Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Medicenna Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2021 2022 2024 (projected)
Net Debt To EBITDA0.912.061.61
Intangibles To Total Assets0.0027710.0016740.00283

Medicenna Therapeutics December 12, 2024 Technical Indicators

Most technical analysis of Medicenna help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Medicenna from various momentum indicators to cycle indicators. When you analyze Medicenna charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Medicenna Therapeutics December 12, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Medicenna stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Other Information on Investing in Medicenna Stock

Medicenna Therapeutics financial ratios help investors to determine whether Medicenna Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medicenna with respect to the benefits of owning Medicenna Therapeutics security.